PMN (ProMIS Neurosciences, Inc.) Stock Market Reviews

crown

search

Read and share opinions on PMN (ProMIS Neurosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

PMN

ProMIS Neurosciences, Inc.

clarify Biotechnology

bookmark Healthcare

public Canada

Sell Neutral Buy

Latest News

ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
Nov 12, 2025
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Nov 3, 2025
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
Oct 22, 2025
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
Sep 3, 2025
Phoenix Mecano's (VTX:PMN) Soft Earnings Are Actually Better Than They Appear
Aug 27, 2025
Phoenix Mecano AG (VTX:PMN) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 23, 2025
Phoenix Mecano First Half 2025 Earnings: EPS: €14.90 (vs €18.00 in 1H 2024)
Aug 20, 2025
ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights
Aug 13, 2025
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
Jul 29, 2025
ProMIS Neurosciences Announces Private Placement Financing
Jul 28, 2025
ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules
Jul 22, 2025
ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
Jul 21, 2025
Are Strong Financial Prospects The Force That Is Driving The Momentum In Phoenix Mecano AG's VTX:PMN) Stock?
Jul 5, 2025

Reviews